BACKGROUND: The occurrence of and risk factors for postoperative cervical hematoma remain unclear. METHODS: We conducted a retrospective analysis of 5156 patients treated at a single institution. RESULTS: The occurrence of postoperative cervical hematoma was 0.85% (44 of 5156 patients). The multivariate analysis showed that male sex, benign pathology, hypertension, and previous thyroid surgery are individual risk factors with odds ratios of 1.906, 2.004, 7.962, and 4.407, respectively. The majority (88.7%) of hematomas occurred within 12 hours after surgery. Obvious bleeding points were detected in 28 cases (73.6%) during reexploration, surface of the strap muscle, superior thyroid vessel, and end of the recurrent laryngeal nerve were the most frequent bleeding sources. CONCLUSION: Hematoma often occurs within 12 hours after thyroid surgery. Hypertension, previous thyroid surgery, male sex, and benign pathology may increase the risk of hematoma.
BACKGROUND: The occurrence of and risk factors for postoperative cervical hematoma remain unclear. METHODS: We conducted a retrospective analysis of 5156 patients treated at a single institution. RESULTS: The occurrence of postoperative cervical hematoma was 0.85% (44 of 5156 patients). The multivariate analysis showed that male sex, benign pathology, hypertension, and previous thyroid surgery are individual risk factors with odds ratios of 1.906, 2.004, 7.962, and 4.407, respectively. The majority (88.7%) of hematomas occurred within 12 hours after surgery. Obvious bleeding points were detected in 28 cases (73.6%) during reexploration, surface of the strap muscle, superior thyroid vessel, and end of the recurrent laryngeal nerve were the most frequent bleeding sources. CONCLUSION:Hematoma often occurs within 12 hours after thyroid surgery. Hypertension, previous thyroid surgery, male sex, and benign pathology may increase the risk of hematoma.
Authors: Sarah C Oltmann; Amal Y Alhefdhi; Mohammad H Rajaei; David F Schneider; Rebecca S Sippel; Herbert Chen Journal: Ann Surg Oncol Date: 2016-05-02 Impact factor: 5.344